Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
82.00
Ask:
87.00
Spread: 5.00 (6.098%)
Market Cap: £85.91m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Board Composition

31 Dec 2025 07:00

RNS Number : 1990N
Inspecs Group PLC
31 December 2025
Β 

31 December 2025

Β 

Inspecs Group plc

("Inspecs", "the Company" or "the Group")

Β 

Board Composition

Β 

Inspecs Group plc, a leading designer, manufacturer, and distributor of eyewear (sunglasses, optical frames and low vision products) announces an update to its Board and Executive composition in light of the recommended acquisition of Inspecs by Bidco 1125 Limited, a newly formed company indirectly owned by Luke Johnson and Ian Livingstone (the "Offer").

Β 

On 29 May 2025, it was announced that Robin Totterman, Executive Director, would step down from the Board on 31 December 2025 with Christopher Hancock, the Company's Senior Independent Director, becoming Interim Chair until the appointment of a new Chair. Given the Offer, and his continued involvement in support of that process, Robin will continue to be a member of the Inspecs Board until the conclusion of the offer period.

Β 

On 18 September 2025 it was also announced that Andrea Davis would be appointed as Non-Executive Chair on or before 31 December 2025. On account of the Offer, Andrea will no longer assume the role as previously announced, instead Christopher Hancock will remain as Interim Chair. However, Andrea has agreed to make herself available to join the Board, if required, should the Offer lapse.

Β 

As previously announced, having stepped down from the Board at the Company's AGM in June 2025, Chris Kay will step down as Chief Financial Officer upon appointment of a successor.

Β 

Β 

For further information please contact:

Β 

Inspecs Group plc

Christopher Hancock (Interim Chair)

Richard Peck (CEO)

Chris Kay (CFO)

Β 

Β 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

George Sellar

Andrew Clark

Β 

Β 

Tel: +44 (0) 20 7418 8900

FTI Consulting (Financial PR)

Alex Beagley

Harriet Jackson

Amy Goldup

Tel: +44 (0) 20 3727 1000

Β 

Β 

About INSPECS Group plc

INSPECS is a leading provider of eyewear solutions to the global eyewear market. The Group produces a broad range of eyewear frames and low vision aids, covering optical, sunglasses and safety, which are either "Branded" (under licence or under the Group's own proprietary brands), or "OEM" (unbranded or private label on behalf of retail customers).

Β 

INSPECS is building a global eyewear business through its vertically integrated business model. Its continued growth is underpinned by increasing the penetration of its own-brand portfolio, worldwide distribution, growing retail presence, maximising group synergies and its global network, expanding its manufacturing capacity and scaling the research and development department as it develops new and innovative eyewear products.

Β 

The Group has operations across the globe: with offices and subsidiaries in the UK, Europe, the US and China (including Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy.

Β 

INSPECS customers are global optical and non-optical retailers, global distributors and independent opticians. Its distribution network covers over 80 countries and reaches approximately 75,000 points of sale.

Β 

More information is available at: www.INSPECS.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOADBLFXELLFFBL
Date   Source Headline
19th May 20269:14 amRNSHolding(s) in Company
19th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSOffer Closed
13th May 20267:00 amRNSFinal Results for the year ended 31 December 2025
1st May 20265:00 pmRNSClosure of the Offer
24th Mar 20267:00 amRNSAcceptance Level Update
18th Mar 202611:42 amRNSHolding(s) in Company
17th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
17th Mar 20269:16 amRNSForm 8.3 - INSPECS GROUP PLC
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
16th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
16th Mar 20268:44 amRNSForm 8.3 - INSPECS GROUP PLC
13th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
13th Mar 20267:00 amRNSOffer Declared Unconditional
13th Mar 20267:00 amRNSOffer Declared Unconditional
11th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202610:40 amRNSHolding(s) in Company
10th Mar 20268:54 amRNSForm 8.3 - INSPECS GROUP PLC
9th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
9th Mar 20269:17 amRNSForm 8.3 - INSPECS GROUP PLC
6th Mar 20261:02 pmRNSForm 8.3 - Inspecs Group Plc
6th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
6th Mar 20269:26 amRNSForm 8.3 - INSPECS GROUP PLC
5th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
5th Mar 20269:32 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20265:00 pmRNSSatisfaction of NSIA Condition
4th Mar 20261:20 pmRNSAIM Rules Confirmation
4th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
4th Mar 20269:30 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20268:34 amBUSForm 8.3 - Inspecs Group Plc
3rd Mar 20265:22 pmRNSHolding(s) in Company
3rd Mar 20264:38 pmRNSForm 8.3 - Inspecs Group PLC
3rd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
2nd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
27th Feb 20261:09 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
26th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 20269:10 amGNWForm 8.3 - Inspecs Group Plc
23rd Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
23rd Feb 202611:46 amRNSHolding(s) in Company
23rd Feb 202611:30 amRNSPublication of the Offer Document
20th Feb 20266:32 pmRNSSwitch to a Takeover Offer
20th Feb 20266:01 pmRNSSwitch to a Takover Offer
20th Feb 20264:30 pmRNSForm 8.3 - INSPECS GROUP PLC
20th Feb 20264:01 pmBUSForm 8.3

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.